ema prac naion semaglutide very rare side effect 2025 may cause blindness—US study warning adds to growing debate on Novo's Ozempic linked to rare

The added GIP receptor activation (glucose-dependent insulinotropic polypeptide) brings a second metabolic dimension, further enhancing insulin sensitivity, supporting fat metabolism in adipose tissue, and amplifying the appetite-reducing effects of GLP-1 activation through complementary neural pathways

MOTS-c and NAD+ keep mitochondria firing to provide energy, endurance, and muscle preservation through better fuel usage, which helps offset the fatigue, lethargy, and a general sense of unwellness sometimes accompanied due to rapid weight loss and calorie deficit

2) They are both injected but come in different strengths

No jargon soup, no lab-coat lecture